サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1434929

急性期用脳室ドレーン市場：患者タイプ別、用途別-2024-2030年の世界予測

Acute External Ventricular Drain Market by Patient Type (Adult, Pediatric), Application (Intracerebral Hemorrhage, Non-Traumatic Hydrocephalus Conditions, Subarachnoid Hemorrhage) - Global Forecast 2024-2030
出版日: | 発行: 360iResearch | ページ情報: 英文 182 Pages | 納期: 即日から翌営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=157.14円
急性期用脳室ドレーン市場：患者タイプ別、用途別-2024-2030年の世界予測
出版日: 2024年01月15日
発行: 360iResearch
ページ情報: 英文 182 Pages
納期: 即日から翌営業日
ご注意事項 :
本レポートは最新情報反映のため適宜更新し、内容構成変更を行う場合があります。ご検討の際はお問い合わせください。
  • 全表示
  • 概要
  • 図表
  • 目次
概要

急性期用脳室ドレーン市場規模は、2023年に2億4,346万米ドルと推定され、2024年には2億6,664万米ドルに達し、CAGR 9.95%で2030年には4億7,319万米ドルに達すると予測されています。

急性期用脳室ドレーンの世界市場

主な市場の統計
基準年[2023］ 2億4,346万米ドル
予測年[2024] 2億6,664万米ドル
予測年 [2030] 4億7,319万米ドル
CAGR（%） 9.95%
急性期用脳室ドレーン Market-IMG1

FPNVポジショニング・マトリックス

FPNVポジショニングマトリックスは急性期用脳室ドレーン市場を評価する上で極めて重要です。事業戦略と製品満足度に関連する主要指標を調査し、ベンダーの包括的な評価を提供します。この綿密な分析により、ユーザーは各自の要件に沿った十分な情報に基づいた意思決定を行うことができます。評価に基づき、ベンダーは成功の度合いが異なる4つの象限に分類されます：フォアフロント（F）、パスファインダー（P）、ニッチ（N）、バイタル（V）です。

市場シェア分析

市場シェア分析は、急性期用脳室ドレーン市場におけるベンダーの現状について、洞察に満ちた詳細な調査を提供する包括的なツールです。全体的な収益、顧客基盤、その他の主要指標についてベンダーの貢献度を綿密に比較・分析することで、企業の業績や市場シェア争いの際に直面する課題について理解を深めることができます。さらに、この分析により、調査対象基準年に観察された累積、断片化の優位性、合併の特徴などの要因を含む、この分野の競合特性に関する貴重な考察が得られます。このような詳細レベルの拡大により、ベンダーはより多くの情報に基づいた意思決定を行い、市場で競争優位に立つための効果的な戦略を考案することができます。

本レポートは、以下の側面に関する貴重な洞察を提供しています：

1-市場の浸透度：主要企業が提供する市場に関する包括的な情報を提示しています。

2-市場の開拓度：有利な新興市場を深く掘り下げ、成熟市場セグメントにおける浸透度を分析しています。

3-市場の多様化：新製品の発売、未開拓の地域、最近の開発、投資に関する詳細な情報を提供します。

4-競合の評価と情報：市場シェア、戦略、製品、認証、規制状況、特許状況、主要企業の製造能力などを網羅的に評価します。

5-製品開発およびイノベーション：将来の技術、研究開発活動、画期的な製品開発に関する知的洞察を提供します。

本レポートは、以下のような主要な質問に対応しています：

1-急性期用脳室ドレーン市場の市場規模および予測は？

2-急性期用脳室ドレーン市場の予測期間中に投資を検討すべき製品、セグメント、用途、分野は何か？

3-急性期用脳室ドレーン市場における技術動向と規制の枠組みは？

4-急性期用脳室ドレーン市場における主要ベンダーの市場シェアは？

5-急性期用脳室ドレーン市場への参入に適した形態や戦略的手段は？

目次

第1章 序文

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 市場の概要

第5章 市場洞察

  • 市場力学
    • 促進要因
      • 非外傷性水頭症の世界の蔓延
      • 患者の神経学的状態を監視および制御する必要性
      • 低侵襲医療処置に対する患者の傾向
    • 抑制要因
      • 治療期間や治療期間が不明確
    • 機会
      • EVD移植におけるリアルタイム超音波ナビゲーションの使用の増加
      • 世界中で医療ツーリズム活動が増加
    • 課題
      • 急性期用脳室ドレーンに関連するリスク
  • 市場セグメンテーション分析
  • 市場動向分析
  • 高インフレの累積的影響
  • ポーターのファイブフォース分析
  • バリューチェーンとクリティカルパス分析
  • 規制の枠組み

第6章 急性期用脳室ドレーン市場患者タイプ別

  • 成人用
  • 小児

第7章 急性期用脳室ドレーン市場：用途別

  • 脳内出血
  • 非外傷性水頭症の状態
  • くも膜下出血
  • 外傷性脳損傷

第8章 南北アメリカの急性期用脳室ドレーン市場

  • アルゼンチン
  • ブラジル
  • カナダ
  • メキシコ
  • 米国

第9章 アジア太平洋地域の急性期用脳室ドレーン市場

  • オーストラリア
  • 中国
  • インド
  • インドネシア
  • 日本
  • マレーシア
  • フィリピン
  • シンガポール
  • 韓国
  • 台湾
  • タイ
  • ベトナム

第10章 欧州・中東・アフリカの急性期用脳室ドレーン市場

  • デンマーク
  • エジプト
  • フィンランド
  • フランス
  • ドイツ
  • イスラエル
  • イタリア
  • オランダ
  • ナイジェリア
  • ノルウェー
  • ポーランド
  • カタール
  • ロシア
  • サウジアラビア
  • 南アフリカ
  • スペイン
  • スウェーデン
  • スイス
  • トルコ
  • アラブ首長国連邦
  • 英国

第11章 競合情勢

  • FPNVポジショニングマトリクス
  • 市場シェア分析：主要企業別
  • 競合シナリオ主要企業別の分析

第12章 競争力のあるポートフォリオ

  • 主要な企業プロファイル
    • B. Braun Medical Inc.
    • Bicakcilar Medical Devices Industry and Trade Inc.
    • Brain Navi Biotechnology Co., Ltd.
    • Cadila Pharmaceuticals Limited
    • Cook Group Incorporated
    • Dispomedica GmbH
    • Fuji Systems Co. Ltd.
    • G. Surgiwear Ltd.
    • Geistlich Pharma Inc.
    • Integra LifeSciences Corporation
    • Johnson & Johnson Services, Inc.
    • Medtronic Plc
    • Merit Medical Systems
    • Moller Medical Gmbh
    • Natus Medical Incorporated
    • Neuromedex GmbH
    • Nipro Corporation
    • Pfizer Inc.
    • Raumedic AG
    • Salvavidas Pharmaceutical Pvt. Ltd
    • Silmag S.A.
    • Sophysa SA
    • Spiegelberg Gmbh & Co. Kg
    • Wellong Instruments Co., Ltd.
    • Yushin Medical Co., Ltd.
  • 主要な製品ポートフォリオ

第13章 付録

  • ディスカッションガイド
  • ライセンスと価格について
図表

LIST OF FIGURES

  • FIGURE 1. ACUTE EXTERNAL VENTRICULAR DRAIN MARKET RESEARCH PROCESS
  • FIGURE 2. ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, 2023 VS 2030
  • FIGURE 3. ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY REGION, 2023 VS 2030 (%)
  • FIGURE 5. ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. ACUTE EXTERNAL VENTRICULAR DRAIN MARKET DYNAMICS
  • FIGURE 7. ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY PATIENT TYPE, 2023 VS 2030 (%)
  • FIGURE 8. ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY PATIENT TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 9. ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
  • FIGURE 10. ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 11. AMERICAS ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 12. AMERICAS ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 13. UNITED STATES ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 14. UNITED STATES ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 15. ASIA-PACIFIC ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 16. ASIA-PACIFIC ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 17. EUROPE, MIDDLE EAST & AFRICA ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 18. EUROPE, MIDDLE EAST & AFRICA ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 19. ACUTE EXTERNAL VENTRICULAR DRAIN MARKET, FPNV POSITIONING MATRIX, 2023
  • FIGURE 20. ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SHARE, BY KEY PLAYER, 2023

LIST OF TABLES

  • TABLE 1. ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 6. ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY ADULT, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 7. ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY PEDIATRIC, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 8. ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 9. ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY INTRACEREBRAL HEMORRHAGE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY NON-TRAUMATIC HYDROCEPHALUS CONDITIONS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY SUBARACHNOID HEMORRHAGE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY TRAUMATIC BRAIN INJURY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. AMERICAS ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 14. AMERICAS ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 15. AMERICAS ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 16. ARGENTINA ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 17. ARGENTINA ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 18. BRAZIL ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 19. BRAZIL ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 20. CANADA ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 21. CANADA ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 22. MEXICO ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 23. MEXICO ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 24. UNITED STATES ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 25. UNITED STATES ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 26. UNITED STATES ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 27. ASIA-PACIFIC ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 28. ASIA-PACIFIC ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 29. ASIA-PACIFIC ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 30. AUSTRALIA ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 31. AUSTRALIA ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 32. CHINA ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 33. CHINA ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 34. INDIA ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 35. INDIA ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 36. INDONESIA ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 37. INDONESIA ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 38. JAPAN ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 39. JAPAN ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 40. MALAYSIA ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 41. MALAYSIA ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 42. PHILIPPINES ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 43. PHILIPPINES ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 44. SINGAPORE ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 45. SINGAPORE ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 46. SOUTH KOREA ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 47. SOUTH KOREA ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 48. TAIWAN ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 49. TAIWAN ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 50. THAILAND ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 51. THAILAND ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 52. VIETNAM ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 53. VIETNAM ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 54. EUROPE, MIDDLE EAST & AFRICA ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 55. EUROPE, MIDDLE EAST & AFRICA ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 56. EUROPE, MIDDLE EAST & AFRICA ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 57. DENMARK ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 58. DENMARK ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 59. EGYPT ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 60. EGYPT ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 61. FINLAND ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 62. FINLAND ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 63. FRANCE ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 64. FRANCE ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 65. GERMANY ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 66. GERMANY ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 67. ISRAEL ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 68. ISRAEL ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 69. ITALY ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 70. ITALY ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 71. NETHERLANDS ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 72. NETHERLANDS ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 73. NIGERIA ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 74. NIGERIA ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 75. NORWAY ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 76. NORWAY ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 77. POLAND ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 78. POLAND ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 79. QATAR ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 80. QATAR ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 81. RUSSIA ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 82. RUSSIA ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 83. SAUDI ARABIA ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 84. SAUDI ARABIA ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 85. SOUTH AFRICA ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 86. SOUTH AFRICA ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 87. SPAIN ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 88. SPAIN ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 89. SWEDEN ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 90. SWEDEN ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 91. SWITZERLAND ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 92. SWITZERLAND ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 93. TURKEY ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 94. TURKEY ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 95. UNITED ARAB EMIRATES ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 96. UNITED ARAB EMIRATES ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 97. UNITED KINGDOM ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 98. UNITED KINGDOM ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 99. ACUTE EXTERNAL VENTRICULAR DRAIN MARKET, FPNV POSITIONING MATRIX, 2023
  • TABLE 100. ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 101. ACUTE EXTERNAL VENTRICULAR DRAIN MARKET LICENSE & PRICING
目次
Product Code: MRR-957C47F8FEE8

[182 Pages Report] The Acute External Ventricular Drain Market size was estimated at USD 243.46 million in 2023 and expected to reach USD 266.64 million in 2024, at a CAGR 9.95% to reach USD 473.19 million by 2030.

Global Acute External Ventricular Drain Market

KEY MARKET STATISTICS
Base Year [2023] USD 243.46 million
Estimated Year [2024] USD 266.64 million
Forecast Year [2030] USD 473.19 million
CAGR (%) 9.95%
Acute External Ventricular Drain Market - IMG1

FPNV Positioning Matrix

The FPNV Positioning Matrix is pivotal in evaluating the Acute External Ventricular Drain Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the Acute External Ventricular Drain Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Key Company Profiles

The report delves into recent significant developments in the Acute External Ventricular Drain Market, highlighting leading vendors and their innovative profiles. These include B. Braun Medical Inc., Bicakcilar Medical Devices Industry and Trade Inc., Brain Navi Biotechnology Co., Ltd., Cadila Pharmaceuticals Limited, Cook Group Incorporated, Dispomedica GmbH, Fuji Systems Co. Ltd., G. Surgiwear Ltd., Geistlich Pharma Inc., Integra LifeSciences Corporation, Johnson & Johnson Services, Inc., Medtronic Plc, Merit Medical Systems, Moller Medical Gmbh, Natus Medical Incorporated, Neuromedex GmbH, Nipro Corporation, Pfizer Inc., Raumedic AG, Salvavidas Pharmaceutical Pvt. Ltd, Silmag S.A., Sophysa SA, Spiegelberg Gmbh & Co. Kg, Wellong Instruments Co., Ltd., and Yushin Medical Co., Ltd..

Market Segmentation & Coverage

This research report categorizes the Acute External Ventricular Drain Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Patient Type
    • Adult
    • Pediatric
  • Application
    • Intracerebral Hemorrhage
    • Non-Traumatic Hydrocephalus Conditions
    • Subarachnoid Hemorrhage
    • Traumatic Brain Injury
  • Region
    • Americas
      • Argentina
      • Brazil
      • Canada
      • Mexico
      • United States
        • California
        • Florida
        • Illinois
        • New York
        • Ohio
        • Pennsylvania
        • Texas
    • Asia-Pacific
      • Australia
      • China
      • India
      • Indonesia
      • Japan
      • Malaysia
      • Philippines
      • Singapore
      • South Korea
      • Taiwan
      • Thailand
      • Vietnam
    • Europe, Middle East & Africa
      • Denmark
      • Egypt
      • Finland
      • France
      • Germany
      • Israel
      • Italy
      • Netherlands
      • Nigeria
      • Norway
      • Poland
      • Qatar
      • Russia
      • Saudi Arabia
      • South Africa
      • Spain
      • Sweden
      • Switzerland
      • Turkey
      • United Arab Emirates
      • United Kingdom

The report offers valuable insights on the following aspects:

1. Market Penetration: It presents comprehensive information on the market provided by key players.

2. Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.

3. Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.

4. Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.

5. Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.

The report addresses key questions such as:

1. What is the market size and forecast of the Acute External Ventricular Drain Market?

2. Which products, segments, applications, and areas should one consider investing in over the forecast period in the Acute External Ventricular Drain Market?

3. What are the technology trends and regulatory frameworks in the Acute External Ventricular Drain Market?

4. What is the market share of the leading vendors in the Acute External Ventricular Drain Market?

5. Which modes and strategic moves are suitable for entering the Acute External Ventricular Drain Market?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Limitations
  • 1.7. Assumptions
  • 1.8. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

  • 4.1. Introduction
  • 4.2. Acute External Ventricular Drain Market, by Region

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Prevalence of non-traumatic hydrocephalus globally
      • 5.1.1.2. Need for monitoring and regulating the neurologic status of patients
      • 5.1.1.3. Inclination of patients toward minimally invasive medical procedures
    • 5.1.2. Restraints
      • 5.1.2.1. Uncertain time and duration of treatment
    • 5.1.3. Opportunities
      • 5.1.3.1. Rising use of real-time ultrasound navigation for EVD implantation
      • 5.1.3.2. Increasing medical tourism activities worldwide
    • 5.1.4. Challenges
      • 5.1.4.1. Risks associated with acute external ventricular drain
  • 5.2. Market Segmentation Analysis
  • 5.3. Market Trend Analysis
  • 5.4. Cumulative Impact of High Inflation
  • 5.5. Porter's Five Forces Analysis
    • 5.5.1. Threat of New Entrants
    • 5.5.2. Threat of Substitutes
    • 5.5.3. Bargaining Power of Customers
    • 5.5.4. Bargaining Power of Suppliers
    • 5.5.5. Industry Rivalry
  • 5.6. Value Chain & Critical Path Analysis
  • 5.7. Regulatory Framework

6. Acute External Ventricular Drain Market, by Patient Type

  • 6.1. Introduction
  • 6.2. Adult
  • 6.3. Pediatric

7. Acute External Ventricular Drain Market, by Application

  • 7.1. Introduction
  • 7.2. Intracerebral Hemorrhage
  • 7.3. Non-Traumatic Hydrocephalus Conditions
  • 7.4. Subarachnoid Hemorrhage
  • 7.5. Traumatic Brain Injury

8. Americas Acute External Ventricular Drain Market

  • 8.1. Introduction
  • 8.2. Argentina
  • 8.3. Brazil
  • 8.4. Canada
  • 8.5. Mexico
  • 8.6. United States

9. Asia-Pacific Acute External Ventricular Drain Market

  • 9.1. Introduction
  • 9.2. Australia
  • 9.3. China
  • 9.4. India
  • 9.5. Indonesia
  • 9.6. Japan
  • 9.7. Malaysia
  • 9.8. Philippines
  • 9.9. Singapore
  • 9.10. South Korea
  • 9.11. Taiwan
  • 9.12. Thailand
  • 9.13. Vietnam

10. Europe, Middle East & Africa Acute External Ventricular Drain Market

  • 10.1. Introduction
  • 10.2. Denmark
  • 10.3. Egypt
  • 10.4. Finland
  • 10.5. France
  • 10.6. Germany
  • 10.7. Israel
  • 10.8. Italy
  • 10.9. Netherlands
  • 10.10. Nigeria
  • 10.11. Norway
  • 10.12. Poland
  • 10.13. Qatar
  • 10.14. Russia
  • 10.15. Saudi Arabia
  • 10.16. South Africa
  • 10.17. Spain
  • 10.18. Sweden
  • 10.19. Switzerland
  • 10.20. Turkey
  • 10.21. United Arab Emirates
  • 10.22. United Kingdom

11. Competitive Landscape

  • 11.1. FPNV Positioning Matrix
  • 11.2. Market Share Analysis, By Key Player
  • 11.3. Competitive Scenario Analysis, By Key Player

12. Competitive Portfolio

  • 12.1. Key Company Profiles
    • 12.1.1. B. Braun Medical Inc.
    • 12.1.2. Bicakcilar Medical Devices Industry and Trade Inc.
    • 12.1.3. Brain Navi Biotechnology Co., Ltd.
    • 12.1.4. Cadila Pharmaceuticals Limited
    • 12.1.5. Cook Group Incorporated
    • 12.1.6. Dispomedica GmbH
    • 12.1.7. Fuji Systems Co. Ltd.
    • 12.1.8. G. Surgiwear Ltd.
    • 12.1.9. Geistlich Pharma Inc.
    • 12.1.10. Integra LifeSciences Corporation
    • 12.1.11. Johnson & Johnson Services, Inc.
    • 12.1.12. Medtronic Plc
    • 12.1.13. Merit Medical Systems
    • 12.1.14. Moller Medical Gmbh
    • 12.1.15. Natus Medical Incorporated
    • 12.1.16. Neuromedex GmbH
    • 12.1.17. Nipro Corporation
    • 12.1.18. Pfizer Inc.
    • 12.1.19. Raumedic AG
    • 12.1.20. Salvavidas Pharmaceutical Pvt. Ltd
    • 12.1.21. Silmag S.A.
    • 12.1.22. Sophysa SA
    • 12.1.23. Spiegelberg Gmbh & Co. Kg
    • 12.1.24. Wellong Instruments Co., Ltd.
    • 12.1.25. Yushin Medical Co., Ltd.
  • 12.2. Key Product Portfolio

13. Appendix

  • 13.1. Discussion Guide
  • 13.2. License & Pricing